Department of Biology and Pharmaceutical Botany, Medical University of Lodz, 90-151 Lodz, Poland.
Department of Molecular Biotechnology and Genetics, Faculty of Biology and Environmental Protection, University of Lodz, 90-237 Lodz, Poland.
Biomolecules. 2021 Oct 14;11(10):1513. doi: 10.3390/biom11101513.
is a rare Chinese medicinal plant that due to the presence of polyphenols lowers the risk of some chronic diseases especially those related to the cardiovascular system. The present study examines the organogenic competence of various combinations and concentrations of plant growth regulators to develop an efficient protocol for in vitro regeneration of via leaf explants, maintaining the high production of active constituents. The purpose of the study was also to assess the possibilities of using a cytokinin-based regeneration to effectively produce therapeutic compounds. The adventitious shoot formation was observed through direct organogenesis on media with purine derivatives (meta-topolin, mT and benzylaminopurine, BAP), and through indirect organogenesis on media with urea derivatives (tidiazuron, TDZ and forchlorfenuron, CPPU). The highest regeneration frequency (95%) with 5.2 shoots per explant was obtained on leaves cultured on Murashige and Skoog (MS) medium containing 0.1 mg/L naphthalene-1-acetic acid (NAA) and 2 mg/L BAP. Following inter simple sequence repeat (ISSR) marker-based profiling, the obtained organogenic shoot lines revealed a similar banding pattern to the mother line, with total variability of 4.2-13.7%, indicating high level of genetic stability. The similar genetic profile of the studied lines translated into similar growth parameters. Moreover, HPLC analysis revealed no qualitative differences in the profile of bioactive metabolites; also, the total polyphenol content was similar for different lines, with the exception of the shoots obtained in the presence of CPPU that produced higher level of bioactive compounds. This is the first report of an effective and rapid in vitro organogenesis protocol for , which can be efficiently employed for obtaining stable cultures rich in bioactive metabolites.
是一种稀有的中药材,由于其多酚含量降低了某些慢性病的风险,特别是与心血管系统相关的疾病。本研究考察了不同组合和浓度的植物生长调节剂对通过叶片外植体进行高效体外再生的器官发生能力,同时保持了活性成分的高产量。该研究的目的还在于评估基于细胞分裂素的再生是否有可能有效地产生治疗化合物。通过嘌呤衍生物(meta-拓扑啉,mT 和苄氨基嘌呤,BAP)的直接器官发生以及通过尿素衍生物(噻苯隆,TDZ 和 氯苯氧脲,CPPU)的间接器官发生观察不定芽的形成。在含有 0.1 mg/L 萘乙酸(NAA)和 2 mg/L BAP 的 Murashige 和 Skoog(MS)培养基上培养叶片,获得了最高的再生频率(95%),每个外植体有 5.2 个芽。继间简单序列重复(ISSR)标记分析之后,获得的器官发生芽系显示出与母系相似的带型模式,总变异性为 4.2-13.7%,表明遗传稳定性很高。研究系的相似遗传模式转化为相似的生长参数。此外,HPLC 分析显示生物活性代谢物的图谱没有定性差异;此外,不同系的总多酚含量相似,除了在 CPPU 存在下获得的芽系产生更高水平的生物活性化合物外。这是首次报道 的有效快速体外器官发生方案,可有效地用于获得富含生物活性代谢物的稳定培养物。